CLINICAL_TRIALS
trial_result
· 2011-05-11
Clinical Trial Update: XP13512 vs. Placebo in Patients With Restless Legs Syndrome. [Phase 3]
Summary
Phase 3 trial comparing XP13512 (gabapentin enacarbil) to placebo in restless legs syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: XenoPort, Inc. | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2011-05-11